SEC Form 4 · accession 0001179110-15-005206

GILEAD SCIENCES, INC. · GILD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, R&D and CSO

Period of report

Mar 16, 2015

Accepted (ET)

Mar 18, 2015 · 7:39 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000882095

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 16, 2015	M	20,000	$16.395	A	185,168	D
Common Stock	Mar 16, 2015	M	50,000	$20.74	A	235,168	D
Common Stock^F3	Mar 16, 2015	S	32,097	$100.3604	D	203,071	D
Common Stock^F4	Mar 16, 2015	S	37,903	$101.1777	D	165,168	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$16.395	Mar 16, 2015	M	20,000	D	—	Jan 22, 2017	Common Stock	20,000	0	D
Non-Qualified Stock Option (right to buy)^F2	$20.74	Mar 16, 2015	M	50,000	D	—	May 8, 2017	Common Stock	50,000	90,000	D

F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3Sale prices reported for the transactions reported here range from $99.81 to $100.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4Sale prices reported for the transactions reported here range from $100.81 to $101.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request